Navigation Links
QBI's PreserveX product passes initial test

Madison, Wis. - Ralph Kauten is taking direct aim at three unfavorable metrics, and one of his newest weapons just passed an early test.

Kauten, CEO of QBI Life Sciences, recently received good news from an initial screening of its PreserveX Polymeric Micelles, a core product. The screening, which employed UGT1A1, an enzyme that metabo......

Full article >>> es that give researchers every reason to believe they may have discovered an effective new drug.

The time consuming and costly nature of drug discovery is one reason that pharmaceutical companies are not working to develop drugs for rare diseases - the cost is higher, and the size of the population that benefits is smaller, making it less likely that "pharma" will recoup its investment.
Full article >>> Kauten said.

Evasive capital?

QBI is a division of Quintessence Biosciences, Inc., which is seeking between $5 million and $10 million in private funding to test its Evade technology in human clinical trials. The technology, developed by UW researchers from a protein that plays a role in digesting food, has been modified to produce a d......

Full article >>>
'"/>

Source:wistechnology.com By Joe Vanden Plas 06/07/06


Related biology technology :

1. cMaster RTplusPCR System for increased sensitivity and product length in RT-PCR
2. Advantages of Roche Applied Science amplification products
3. Find the optimal product for your PCR application
4. Trouble-shooting: No product
5. Find the optimal product for your application
6. Microfluidic analysis of multiplex PCR products for the genotyping of Helicobacter pylori
7. Determination of the Chloramphenicol residues in milk and milk products using LC/MS/MS
8. Using THERMAL DESORPTION GAS CHROMATOGRAPHY for the identification of fragrance and other components in cosmetic products
9. WARF enters licensing agreements for stem cell products
10. Surgical products company wins Governors Business Plan Contest
11. Merge unveils next-generation imaging-informatics product
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:5/19/2016)... DIEGO , May 19, 2016 ... (OTC PINK: RGBP) and (OTC PINK: RGBPP) announced today ... creating the first cord blood based cancer immunotherapeutic ... provisional patent application, Regen described a generation of ... was potentiated by gene silencing.  The product in ...
(Date:5/18/2016)... ... May 18, 2016 , ... Tech Coast Angels (TCA) ... to Cognition Therapeutics at the annual ACA Summit last week in Philadelphia. ... one of ACA’s member angel groups. It is the highest honor available for an ...
(Date:5/18/2016)... May 18, 2016 The Biotech industry ... not mean that there are no opportunities ahead. Today, ActiveWallSt.com ... (NASDAQ: THLD ), Seattle Genetics Inc. (NASDAQ: ... and Ophthotech Corp. (NASDAQ: OPHT ). Sign up ... http://www.activewallst.com/ Threshold Pharmaceuticals Inc.,s ...
(Date:5/18/2016)... ... May 18, 2016 , ... Every day, ... result of asthma complications.* Costing more than $56 billion in direct costs annually, ... , “For too many, the suffering associated with uncontrolled asthma can be overwhelmingly ...
Breaking Biology Technology:
(Date:4/14/2016)... , April 14, 2016 ... and Malware Detection, today announced the appointment of ... the new role. Goldwerger,s leadership appointment comes ... the heels of the deployment of its platform at ... behavioral biometric technology, which discerns unique cognitive and physiological ...
(Date:3/31/2016)... BOCA RATON, Florida , March 31, 2016 /PRNewswire/ ... LEGX ) ("LegacyXChange" or the "Company") ... presentation for potential users of its soon to be ... The video ( https://www.youtube.com/channel/UCyTLBzmZogV1y2D6bDkBX5g ) will also ... by the use of DNA technology to an industry ...
(Date:3/29/2016)... March 29, 2016 LegacyXChange, Inc. ... "LEGX" and SelectaDNA/CSI Protect are pleased to announce our ... in a variety of writing instruments, ensuring athletes signatures ... created collectibles from athletes on LegacyXChange will be assured ... the DNA. Bill Bollander , CEO ...
Breaking Biology News(10 mins):